Metabolite details
Reactome pathways
- No Reactome pathways listed for this metabolite.
Observed in studies
- Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
- A metabolite roadmap of the wood-forming tissue in Populus tremula (UPLC-MS assay; Wood fibre and ray cell tissue)
- Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
- Metabolomic Insights into the Browning of the Peel of Bagging ‘Rui Xue’ Apple Fruit
- Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
- Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
- Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
- Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
- Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
- Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
Observed in differential profiles
- G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
- Fiber_vs_Ray
- G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
- Non_Bagged_Fruits_vs_Bagged_Fruits_With_Browning
- Control_vs_nsPEF_7_day
- WT_vs_WT_Aco
- Control_vs_Lithogenic_Diet
- Control_vs_OXPA_Treatment
- Control_vs_OXPA_Treatment
- G1_PBS_vs_G2_DSS
- LLIR_vs_Control